Johnson Index
The Johnson Index was created in honor of Ann L. Johnson, M.D., a psychiatrist/ psychopharmacologist who retired as a Director of Martek in March 2005, after serving on the Board for 10 years. Dr. Johnson’s interest in the neurological and mental development of infants and children was instrumental in the development of this index. Dr. Johnson was a physician on the psychiatry staff of Mills Peninsula Hospital and the neonatology staff of Children’s Hospital Stanford from 1992 to 2001. She also conducted a private practice in psychiatry and psychopharmacology.
The Johnson Index is a database which tracks the number of infants, toddlers and pregnant/nursing women by year who have received DHA and/or ARA from products enriched with life'sDHA™ and/or life'sARA™. This index may be used by researchers in the future to detect potential reasons for trends in brain, eye and heart health. DHA is a major structural fatty acid in the brain and retina accounting for up to 97% of the omega-3 fatty acids in the brain and up to 93% of the omega-3 fatty acids in the retina. DHA is also a key component of heart tissue.
